The in vitro efficacy of antimicrobial agents against the pathogenic free-living amoeba Balamuthia mandrillaris

Journal of Eukaryotic Microbiology

Volumn 60, Issue 5, 2013, Pages 539-543

  Ahmad, Arine F ^a,b   Heaselgrave, Wayne ^a,c   Andrew, Peter W ^a   Kilvington, Simon ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF WORCESTER   (United Kingdom)

Author keywords

Cyst; diminazene aceturate; drug assays; in vitro culture; trophozoite

Indexed keywords

BIOASSAY; CYST; DRUG; ENCEPHALITIS; PATHOGEN; PROTOZOAN;

AMOEBA (GENUS); ANIMALIA; BALAMUTHIA MANDRILLARIS;

ANTIINFECTIVE AGENT; DIMINAZENE ACETURATE;

ARTICLE; BALAMUTHIA MANDRILLARIS; CELL SURVIVAL; CYST; DRUG ASSAYS; DRUG EFFECT; DRUG SENSITIVITY; IN VITRO CULTURE; PROTOZOAN SPORE; TROPHOZOITE;

CYST; DIMINAZENE ACETURATE; DRUG ASSAYS; IN VITRO CULTURE; TROPHOZOITE;

ANTI-INFECTIVE AGENTS; BALAMUTHIA MANDRILLARIS; CELL SURVIVAL; PARASITIC SENSITIVITY TESTS; SPORES, PROTOZOAN;

EID: 84884130988     PISSN: 10665234     EISSN: 15507408     Source Type: Journal    
DOI: 10.1111/jeu.12062     Document Type: Article

References (30)

1. Abaru, D. E., Liwo, D. A., Isakina, D., &, Okori, E. E., 1984. Retrospective long-term study of effects of berenil by follow-up of patients treated since 1965. Tropenmed. Parasitol., 35: 148-150.
2. Ahmad, A. F., Andrew, P. W., &, Kilvington, S., 2011. Development of a nested PCR for environmental detection of the pathogenic free-living amoeba Balamuthia mandrillaris. J. Eukaryot. Microbiol., 58: 269-271.
3. Bacchi, C., 2009. Chemotherapy of human African trypanosomiasis. Interdiscip. Perspect. Infect. Dis., 2009: 1-5.
4. Byers, T. J., Kim, B. G., King, L. E., &, Hugo, E. R., 1991. Molecular aspects of the cell cycle and encystment of Acanthamoeba. Rev. Infect. Dis., 13 (Suppl. 5): S373-S384.
5. Cary, L. C., Maul, E., Potter, C., Wong, P., Nelson, P. T., Given C., 2nd, &, Robertson W., Jr, 2010. Balamuthia mandrillaris meningoencephalitis: survival of a pediatric patient. Pediatrics, 125: e699-e703.
6. CDC 2008. Balamuthia amebic encephalitis-California, 1999-2007. MMWR Morb. Mortal. Wkly Rep., 57: 768-771.
7. Deetz, T. R., Sawyer, M. H., Billman, G., Schuster, F. L., &, Visvesvara, G. S., 2003. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin. Infect. Dis., 37: 1304-1312.
8. Diaz, J. H., 2011. The public health threat from Balamuthia mandrillaris in the southern United States. J. La. State Med. Soc., 163: 197-204.
9. Dunnebacke, T. H., Schuster, F. L., Yagi, S., &, Booton, G. C., 2003. Isolation of Balamuthia amebas from the environment. J. Eukaryot. Microbiol., 50 (Suppl.): 510-511.
10. Homeida, A. M., El Amin, E. A., Adam, S. E., &, Mahmoud, M. M., 1981. Toxicity of diminazene aceturate (Berenil) to camels. J. Comp. Pathol., 91: 355-360.
11. Hughes, R., &, Kilvington, S., 2001. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob. Agents Chemother., 45: 2038-2043.
12. Hutchinson, M. P., &, Watson, H. J., 1962. Berenil in the treatment of Trypanosoma gambiense infection in man. Trans. R. Soc. Trop. Med. Hyg., 56: 227-230.
13. Janitschke, K., Martinez, A. J., Visvesvara, G. S., &, Schuster, F., 1996. Animal model Balamuthia mandrillaris CNS infection: contrast and comparison in immunodeficient and immunocompetent mice: a murine model of "granulomatous" amebic encephalitis. J. Neuropathol. Exp. Neurol., 55: 815-821.
14. Khaw, M., &, Panosian, C. B., 1995. Human antiprotozoal therapy: past, present, and future. Clin. Microbiol. Rev., 8: 427-439.
15. Kilvington, S., Heaselgrave, W., Lally, J. M., Ambrus, K., &, Powell, H., 2008. Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations. Eye Contact Lens, 34: 133-139.
16. Kroubi, M., Karembe, H., &, Betbeder, D., 2011. Drug delivery systems in the treatment of African trypanosomiasis infections. Expert. Opin. Drug. Deliv., 8: 735-747.
17. Kroubi, M., Daulouede, S., Karembe, H., Jallouli, Y., Howsam, M., Mossalayi, D., Vincendeau, P., &, Betbeder, D., 2010. Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis. Nanotechnology, 21: 505102.
18. Kuriakose, S., Muleme, H. M., Onyilagha, C., Singh, R., Jia, P., &, Uzonna, J. E., 2012. Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection. PLoS ONE, 7: e48696.
19. Maciver, S. K., 2007. The threat from Balamuthia mandrillaris. J. Med. Microbiol., 56: 1-3.
20. Martinez, D. Y., Seas, C., Bravo, F., Legua, P., Ramos, C., Cabello, A. M., &, Gotuzzo, E., 2010. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin. Infect. Dis., 51: 7-11.
21. Matin, A., Siddiqui, R., Jayasekera, S., &, Khan, N. A., 2008. Increasing importance of Balamuthia mandrillaris. Clin. Microbiol. Rev., 21: 435-448.
22. Peregrine, A. S., &, Mamman, M., 1993. Pharmacology of diminazene: a review. Acta. Trop., 54: 185-203.
23. Ruebush 2nd, T. K., Rubin, R. H., Wolpow, E. R., Cassaday, P. B., &, Schultz, M. G., 1979. Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am. J. Trop. Med. Hyg., 28: 184-189.
24. Schuster, F. L., &, Visvesvara, G. L., 1996. Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other anamals. J. Clin. Microbiol., 34: 385-388.
25. Schuster, F. L., &, Visvesvara, G. S., 2008. Balamuthia mandrillaris. In:, Khan, N. A., (ed.), Emerging Protozoan Pathogens. Taylor and Francis, New York, pp. 72-112.
26. Schuster, F. L., Guglielmo, B. J., &, Visvesvara, G. S., 2006. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J. Eukaryot. Microbiol., 53: 121-126.
27. Schuster, F. L., Yagi, S., Gavali, S., Michelson, D., Raghavan, R., Blomquist, I., Glastonbury, C., Bollen, A. W., Scharnhorst, D., Reed, S. L., Kuriyama, S., Visvesvara, G. S., &, Glaser, C. A., 2009. Under the radar: balamuthia amebic encephalitis. Clin. Infect. Dis., 48: 879-887.
28. Siddiqui, R., Matin, A., Warhurst, D., Stins, M., &, Khan, N. A., 2007. Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity. Antimicrob. Agents Chemother., 51: 4471-4473.
29. Sokrab, T. E., Eltahir, A., Idris, M. N., &, Hamid, M., 2002. Guillain-Barre syndrome following acute falciparum malaria. Neurology, 59: 1281-1283.
30. Visvesvara, G. S., Moura, H., &, Schuster, F. L., 2007. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol. Med. Microbiol., 50: 1-26.